MedTrace Logo

ORN Study: Curative Treatment of Osteoradionecrosis (ORN) With Hybrid Bone Substitution

NCT01147315 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2018-04-06

No results posted yet for this study

Summary

The main objective of the study is the cure of osteoradionecrosis (ORN) at 12 months.

Conditions

  • Mandible
  • Osteoradionecrosis

Interventions

PROCEDURE

Hybrid bone substitution

The patient will be treated by hybrid bone substitution with calcium-phosphate ceramic biomaterial and autologous bone marrow after necrosis exeresis

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Olivier Malard, Pr · Nantes University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-18
Primary Completion
2016-11-16
Completion
2016-11-16

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01147315 on ClinicalTrials.gov